Latest Conference

A new study found that transdermal hormone therapy may lower anxiety and depression risk compared with oral therapy in postmenopausal women.

Menopause remains a taboo topic in many cultures, yet women seek to educate themselves and support each other through shared experiences.

A Wake Forest study finds that provider specialty and training shape how women receive medication treatment for menopause symptoms.

Andrew Kaunitz, MD, shares how older women can explore safe contraceptive options while understanding fertility risks.

Most perimenopausal and menopausal women report digestive symptoms, but few receive diagnosis or adequate care, new UK study finds.

Researchers highlight overlap between menopause and TBI symptoms, calling for hormone-informed tools in brain injury assessment.

A review presented at The Menopause Society 2025 highlights the links between menopause-related brain changes and cognitive function.

A large TriNetX analysis found hormone therapy use in postmenopausal women was linked to a higher incidence of autoimmune diseases.

Ethan Lowder, BA, and Alexander Nagrebetsky, MD, MSc, reported that nearly 80% of children fast longer than recommended before surgery.

Check out the top conferences happening in the fourth quarter of 2025.

New research reveals that women face worse heart attack outcomes than men, particularly when treated with beta-blockers, highlighting the need for sex-specific care.

New 14-gene test allows early, precise assessment without partner samples.

A universal aspirin initiative at a Bronx hospital increased prescribing rates from 30% to 99% and is now being evaluated for its impact on preeclampsia.

Considerations for reducing blood loss, morbidity, and surgical complexity in patients with large fibroids.

Find out what you may have missed at the 2025 ACOG ACSM.

Watch some highlights from our discussions with experts presenting at the 2025 ACOG meeting.

A structured surgical approach, imaging tools, and careful platform choice support optimal endometriosis management, according to Trina Mansour, MD, at the 2025 ACOG ACSM.

Tia Welsh, MD, MPH, FACOG, shares new evidence showing that single-use negative pressure wound therapy at -80 mmHg lowers cesarean-section infection rates and healthcare costs more effectively than traditional -125 mmHg therapy.

Amy Valent, DO, MCR, discusses how continuous glucose monitors and smart insulin delivery tools are reshaping individualized care for pregnant patients with diabetes.

Lisa Bayer, MD, MPH, details her presentation at the 2025 ACOG ACSM pain management during IUD placement.

Megan Wasson, DO, discusses surgical precision, imaging, and mentorship to improve endometriosis care at the 2025 ACOG Annual Meeting.

Research presented at the 2025 ACOG ACSM highlighted the potential risks tied to personal care product use among African American pregnant patients.

In an abstract featured at the 2025 ACOG ACSM, researchers found that after Dobbs, North Carolina saw more out-of-state abortion patients, longer wait times, and increased racial disparities.

A comparison of 4 ultrasound-based algorithms demonstrated strong performance, with nuanced implications for clinical practice, according to a new study presented at the 2025 ACOG ACSM.

Megan Cohen, MD, MPH, outlines major changes to the CDC’s 2024 contraceptive recommendations, including updated safety classifications, inclusive language, and new guidance for transgender and medically complex patients.

Megan Wasson, DO, and Ceylan Colak, MD, highlight how imaging and multidisciplinary care improve endometriosis diagnosis, treatment, and patient outcomes at the 2025 ACOG ACSM.

In this interview at the 2025 ACOG ACSM, Johanna Finkle, MD, urged clinicians to tailor weight loss care based on BMI, contraception use, and medication risks using patient-centered counseling.

Erin Keyser, MD, FACOG, breaks down the latest approaches to hormone therapy for menopause, emphasizing personalized care and shared decision-making.